Filing Flows › Pulse Biosciences (PLSE) › Q3 2026 › vs Q3 2025
Pulse Biosciences (PLSE) Q3 2026 vs Q3 2025 (year over year)
Pulse Biosciences's revenue rose $309K (+359%) from $86K in Q3 2025 to $395K in Q3 2026.
Pulse Biosciences, Q3 2026: revenue $395K (+359% year over year), net loss $23.1M, operating cash flow −$15.3M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $395K | $86K | $309K | +359% |
| Other income, net | $1.2M | $982K | $259K | +26% |
| Net loss | $23.1M | $19.4M | $3.7M | +19% |
| Costs & expenses | $24.7M | $20.5M | $4.2M | +21% |
| Operating costs | $24.7M | $20.5M | $4.2M | +21% |
| Cost of revenue | $191K | $279K | −$88K | -32% |
| Research & development | $16.8M | $11.4M | $5.5M | +48% |
| SG&A | $7.6M | $8.8M | −$1.1M | -13% |
| Operating cash sources | $23.1M | $19.4M | $3.7M | +19% |
| Depreciation & amortization | $261K | $266K | −$5K | -2% |
| Share-based compensation | $5.3M | $5.6M | −$305K | -5% |
| Working capital & other | $2.2M | $463K | $1.7M | +376% |
| Cash used in operations | $15.3M | $13.0M | $2.2M | +17% |
| Net loss absorbed | $23.1M | $19.4M | $3.7M | +19% |
Questions
How much did Pulse Biosciences's revenue grow year over year in Q3 2026?
Pulse Biosciences's revenue rose $309K (+359%) from $86K in Q3 2025 to $395K in Q3 2026.